Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MEDEX DANMARK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.3% 2.3%   Bankruptcy risk   5.9% 5.8% 3.0% 6.3% 3.0% 7.9% 16.6% 16.2%   Credit score (0-100)   40 41 57 36 57 30 11 11   Credit rating   BBB BBB BBB BBB BBB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,070 3,245 3,558 3,803 3,639 3,197 0.0 0.0   EBITDA   725 678 663 619 494 186 0.0 0.0   EBIT   595 587 547 500 392 72.9 0.0 0.0   Pre-tax profit (PTP)   344.5 305.7 305.8 348.0 206.8 -564.2 0.0 0.0   Net earnings   261.7 221.6 222.9 348.0 48.3 -563.2 0.0 0.0   Pre-tax profit without non-rec. items   344 306 306 348 207 -564 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   4,366 4,639 4,524 4,436 4,334 4,987 0.0 0.0   Shareholders equity total   -9.6 213 435 783 832 269 144 144   Interest-bearing liabilities   4,069 4,083 5,109 4,871 4,650 4,467 0.0 0.0   Balance sheet total (assets)   6,854 7,299 8,798 10,127 7,874 8,788 144 144   Net Debt   3,868 3,775 3,598 3,788 3,761 3,921 -144 -144     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,070 3,245 3,558 3,803 3,639 3,197 0.0 0.0   Gross profit growth   20.4% 5.7% 9.7% 6.9% -4.3% -12.1% -100.0% 0.0%   Employees   9 9 9 10 10 10 0 0   Employee growth %   0.0% 0.0% 0.0% 11.1% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   6,854 7,299 8,798 10,127 7,874 8,788 144 144   Balance sheet change%   -0.2% 6.5% 20.5% 15.1% -22.2% 11.6% -98.4% 0.0%   Added value   725.1 678.2 662.6 618.6 509.9 186.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -146 182 -230 -205 -204 539 -4,987 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   19.4% 18.1% 15.4% 13.2% 10.8% 2.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.6% 8.4% 6.8% 5.7% 4.4% -4.1% 0.0% 0.0%   ROI %   14.6% 14.2% 11.2% 9.6% 7.1% -6.4% 0.0% 0.0%   ROE %   3.8% 6.3% 68.8% 57.1% 6.0% -102.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -0.1% 2.9% 5.0% 7.8% 10.6% 3.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   533.4% 556.7% 543.0% 612.3% 762.0% 2,102.5% 0.0% 0.0%   Gearing %   -42,399.9% 1,920.7% 1,173.1% 621.8% 559.1% 1,663.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.2% 7.1% 5.3% 3.8% 4.0% 5.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 0.3 1.0 1.0 1.0 0.8 0.0 0.0   Current Ratio   0.6 0.5 1.2 1.2 1.3 0.9 0.0 0.0   Cash and cash equivalent   201.2 307.7 1,511.5 1,083.4 888.8 545.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,893.0 -2,064.9 525.7 777.3 778.8 -188.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   81 75 74 62 51 19 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   81 75 74 62 49 19 0 0   EBIT / employee   66 65 61 50 39 7 0 0   Net earnings / employee   29 25 25 35 5 -56 0 0